Evaluation of ChatGPT as a Reliable Source of Medical Information on Prostate Cancer for Patients: Global Comparative Survey of Medical Oncologists and Urologists
These findings provide insight into how clinicians rate AI-generated and MW-curated responses with evaluation criteria that can be used in future AI validation studies.
Authors
- Cora Nanette Sternberg (ORCID: https://orcid.org/0000-0003-3938-2627)
- Lucile Serfass
- Jochen Walz (ORCID: https://orcid.org/0000-0002-1379-7608)
- Dany Habr (ORCID: https://orcid.org/0000-0002-3361-6309)
- Andrew J. Armstrong (ORCID: https://orcid.org/0000-0001-7012-1754)
- Jennifer Ghith (ORCID: https://orcid.org/0000-0002-3366-6699)
- Kristine W. Schuler
- Andrea Sboner (ORCID: https://orcid.org/0000-0001-6915-3070)
- Dheepa Chari
- Martin Gleave (ORCID: https://orcid.org/0000-0003-4235-0167)
- Arnulf Stenzl (ORCID: https://orcid.org/0000-0003-4207-9928)
- Samer M Garas
- Eamonn Rogers
- Ken Truman
Institutions
- University of British Columbia (CA)
- Pfizer (United States) (US)
- Cornell University (US)
- University Hospital Galway (IE)
- Lander Institute (IL)
- Presbyterian Hospital (US)
- Pfizer (France) (FR)
- Duke Medical Center (US)
- Institut Paoli-Calmettes (FR)
- Weill Cornell Medicine (US)
- Duke Cancer Institute
- University of Tübingen (DE)
Publication Details
- Journal
- Urology Practice
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1097/upj.0000000000000740
- Citations
- 2
- Primary Topic
- Artificial Intelligence in Healthcare and Education
- Type
- article
- Field-Weighted Citation Impact
- 0.24
Funders
- Pfizer
- AstraZeneca
- Astellas Pharma
- Ipsen